A phase I trial of 100mg/m2 docetaxel in patients with advanced or recurrent breast cancer

Tomoki Tamura, Taizo Hirata, Masahiro Tabata, Shiro Hinotsu, Akinobu Hamada, Takayuki Motoki, Takayuki Iwamoto, Taeko Mizoo, Tomohiro Nogami, Tadahiko Shien, Naruto Taira, Junji Matsuoka, Hiroyoshi Doihara

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A phase I trial of 100mg/m<sup>2</sup> docetaxel in patients with advanced or recurrent breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds